文献速递脑血管病外科神经重症

COVID-19患者蛛网膜下腔出血后的手术干预率与院内死亡率

Rates of operative intervention and in-hospital mortality following subarachnoid hemorrhage in patients with COVID-19.
PubMed 文献 · J Neurosurg · 2024-04-05

本研究利用美国国家住院患者样本(NIS)数据库,纳入2020年4月至12月期间6984例非创伤性蛛网膜下腔出血(SAH)患者,其中359例(5.1%)合并COVID-19。结果显示,合并COVID-19的患者接受手术的比例更低(10.0% vs 23.6%,OR 0.35,p < 0.0001),院内死亡率更高(48.2% vs 22.7%,p < 0.0001),且COVID-19是死亡的独立预测因素(OR 1.67,p = 0.0002)。

要点

  • 合并COVID-19的SAH患者手术干预率更低(10.0% vs 23.6%,OR 0.35,p < 0.0001)。
  • 合并COVID-19的SAH患者院内死亡率更高(48.2% vs 22.7%,p < 0.0001)。
  • COVID-19是SAH患者死亡的独立预测因素(OR 1.67,p = 0.0002)。

核心结论

  • COVID-19对非创伤性SAH患者有显著影响:合并COVID-19者接受手术的可能性显著更低,院内死亡率更高;但在接受手术干预的患者中,干预类型无显著差异。
  • 多种因素(从医疗紧急程度到医疗系统限制)可能促成这些发现;需要进一步的回顾性研究以明确干预率降低的具体原因以及COVID-19患者中其他潜在的非动脉瘤性SAH病因。

研究设计与样本

  • 本研究为回顾性研究,使用美国国家住院患者样本(NIS)数据库识别非创伤性SAH患者(ICD-10编码I60.x),排除非动脉瘤性脑血管畸形或创伤性颅内损伤患者。
  • 仅纳入2020年4月至12月期间管理的患者,因该时段有COVID-19的ICD-10编码可用;共6984例患者符合标准,其中359例(5.1%)合并COVID-19。
  • 收集社会人口学因素、医院特征、合并症、NIS SAH严重程度评分(NIS-SSS)、手术治疗和死亡数据;采用多变量分析评估手术干预和院内死亡的预测因素。

主要发现

  • 合并COVID-19的患者更年轻、男性更多,且全患者细化诊断相关组疾病严重程度亚类和NIS-SSS更高。
  • 合并COVID-19的患者接受手术的比例更低(10.0% vs 23.6%,OR 0.35,p < 0.0001),院内死亡率更高(48.2% vs 22.7%,p < 0.0001)。
  • 控制其他变量后,COVID-19是死亡的独立预测因素(OR 1.67,p = 0.0002)。
  • 共1597例患者接受动脉瘤手术(317例开放手术和1280例血管内手术);COVID-19阳性与阴性队列在手术时间或手术类型方面无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步的回顾性研究以明确干预率降低的具体原因以及COVID-19患者中其他潜在的非动脉瘤性SAH病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: COVID-19 had massive effects on the healthcare system and multifactorial implications for the management of intensive care unit and cerebrovascular patients. This study aimed to assess the effect of COVID-19 on the outcomes of patients with aneurysmal subarachnoid hemorrhage (SAH). METHODS: The National Inpatient Sample (NIS) was used to identify patients with nontraumatic SAH (ICD-10 code I60.x). Patients with nonaneurysmal cerebrovascular malformations or traumatic intracranial injuries were excluded. Only patients managed from April to December 2020 were included in the study given the availability of an ICD-10 code for COVID-19. Data on sociodemographic factors, hospital characteristics, comorbidities, NIS SAH Severity Score (NIS-SSS), surgical treatment, and death were acquired. Multivariable analysis was used to assess predictors of both surgical intervention and in-hospital mortality. RESULTS: In total, 6984 patients met the study criteria, 359 (5.1%) of whom had COVID-19. Those with COVID-19 were more likely to be younger and male and had a higher All Patient Refined Diagnosis-Related Groups illness severity subclass, and NIS-SSS. Moreover, patients with COVID-19 were less likely to undergo surgery (10.0% vs 23.6%, OR 0.35, p < 0.0001) and had significantly higher mortality rates (48.2% vs 22.7%, p < 0.0001). When controlling for other variables, COVID-19 was an independent predictor of death (OR 1.67, p = 0.0002). Aneurysm surgery was performed in 1597 patients (317 open and 1280 endovascular procedures). There was no difference between the cohorts positive and negative for COVID-19 in terms of time to surgery or type of surgery. CONCLUSIONS: COVID-19 had significant impacts on patients with nontraumatic SAH. Specifically, patients with COVID-19 were significantly less likely to undergo surgery and had higher in-hospital mortality rates; however, for patients who did undergo procedural intervention, there was no significant difference in the type of intervention. Multiple factors, from medical acuity to healthcare system limitations, may contribute to these findings. Further retrospective research is needed to identify both specific causes of lower intervention rates and other potential nonaneurysmal causes of SAH in patients with COVID-19.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Dallas J, Fixman B, Ding L, et al. Rates of operative intervention and in-hospital mortality following subarachnoid hemorrhage in patients with COVID-19. J Neurosurg. 2024. PMID: 38579339. doi:10.3171/2024.1.JNS231734

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。